Cardiovascular Pharmacotherapeutics: Abridged and Updated

Cardiovascular Pharmacotherapeutics: Abridged and Updated




Cardiovascular Pharmacotherapeutics: Abridged and Updated provides current, on-the-spot information on how to use every approved cardiovascular drug in adults and children, and the scientific rationale for their clinical use. A clinical distillation of the editors' comprehensive and highly respected Cardiovascular Pharmacotherapeutics 3rd edition textbook, this treatment-centered abridgement features:
• Indications, contraindications, dosage, side effects, pharmacokinetics, and adverse reactions for all approved cardiovascular drugs, including the newest therapeutic agents to become available
• Rationales and usage guidelines for therapeutic strategies
• Abundant tables and charts that summarize important clinical choices
• Handy appendices that review approved uses of cardiovascular agents and their pharmacologic characteristics
• Considerations for managing patients on multi-drug regimens
• Details on drug-drug interactions
• Updated information on alternative medicine approaches to cardiovascular disease NEW FEATURES: New with the third edition is an accompanying website,, which highlights advances in cardiovascular drug therapy. Along with providing periodic updates to each chapter, including links to the latest studies, the site reviews cardiovascular drugs newly approved by the FDA for clinical use as well as drugs under investigation. Readers are invited to use the website to communicate directly with the book's authors regarding topics related to cardiovascular drug use. This book is an abridged and updated version of Cardiovascular Pharmacotherapeutics. Compared to the hardcover 3rd edition, it excludes part 1 (with the exception of the first chapter), includes all of part 2, excludes part 3 (with the exception of chapters 30 and 31), and includes appendices 1 and 2; appendices 3-8 are excluded.

Product Details

ISBN-13: 9781935395522
Publisher: Cardiotext Publishing
Publication date: 11/01/2011
Edition description: Abridged
Pages: 616

About the Author

William H. Frishman, MD, Barbara and William Rosenthal Professor and Chairman, Department of Medicine, and Professor of Pharmacology, New York Medical College; Director, Department of Medicine, Westchester Medical Center, Valhalla, New York

Domenic A. Sica, MD, Professor of Medicine and Pharmacology and Eminent Scholar, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia

Table of Contents

Part 1: Introduction: 1. Basic Principles of Clinical Pharmacology Relevant to Cardiology, William H. Frishman
Part 2: Drug Classes: 5. Alpha- and Beta-Adrenergic Blocking Drugs
William H. Frishman
6. Central and Peripheral Sympatholytics
Lawrence R. Krakoff & William H. Frishman
7. Cholinergic and Anticholinergic Drugs
William H. Frishman & B. Robert Meyer
8. Calcium Channel Blockers
William H. Frishman & Domenic A. Sica
9. The Renin-Angiotensin Axis: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Domenic A. Sica, Todd W. B. Gehr, & William H. Frishman
10. The Renin-Angiotensin Axis: Direct Renin Inhibition
William H. Frishman & Domenic A. Sica
11. Diuretic Therapy in Cardiovascular Disease
Domenic A. Sica, Todd W. B. Gehr, & William H. Frishman
12. Magnesium, Potassium, and Calcium as Cardiovascular Disease Therapies
Domenic A. Sica & William H. Frishman
13. Inotropic Agents
Thierry H. LeJemtel, Marc Klapholz, & William H. Frishman
14. The Organic Nitrates and Nitroprusside
Jonathan Abrams & William H. Frishman
15. Ranolazine: A Piperazine Derivative
William H. Frishman, James J. Nawarskas, & Joe R. Anderson
16. Nonspecific Antihypertensive Vasodilators
Lawrence R. Krakoff & William H. Frishman
17. Antiarrhythmic Drugs
Peter Zimetbaum, Peter R. Kowey, & Eric L. Michelson
18. Antiplatelet and Other Antithrombotic Drugs
William H. Frishman, Robert G. Lerner, & Harit Desai
19. Thrombolytic Agents
Robert Forman & William H. Frishman
20. Lipid-Lowering Drugs
William H. Frishman & Wilbert S. Aronow
21. New Aspects of Combination Therapy: Focus on Hypertension
Michael A. Weber
22. Pharmacotherapy for Smoking Cessation
William H. Frishman
23. Pharmacotherapy of Obesity
William H. Frishman, Harriette R. Mogul, & Stephen J. Peterson
24. Heart Disease and Treatment of Diabetes Mellitus
Irene A. Weiss, Guy Valiquette, Monica D. Schwarcz, & William H. Frishman
25. Prostacyclins, Endothelin Inhibitors, and Phosphodiesterase-5 Inhibitors in Pulmonary Hypertension
Warren D. Rosenblum & William H. Frishman
26. Selective and Nonselective Dopamine-Receptor Agonists
William H. Frishman and Chandrasekar Palaniswamy
27. Natriuretic Peptides: Nesiritide
William H. Frishman & Domenic A. Sica
28. Vasopressin and Vasopressin Receptor Antagonists
William H. Frishman, Marc Klapholz, Gerard Oghlakian, & Jacqueline M. Cook
29. Drug-Eluting Stents
James J. Nawarskas & Mark J. Ricciardi
30. Alternative and Complementary Medicine for Preventing and Treating Cardiovascular Disease
William H. Frishman
31. Cardiovascular Drug-Drug Interactions
Angela Cheng-Lai, James J. Nawarskas, & William H. Frishman
Angela Cheng-Lai & William H. Frishman
1. Pharmacokinetic Properties of Approved Cardiovascular Drugs
2. Therapeutic Use of Available Cardiovascular Drugs

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews